Scribe Therapeutics Inc. (SCTX)
NASDAQ: SCTX · Real-Time Price · USD
20.40
+2.04 (11.11%)
At close: Jul 30, 2026, 4:00 PM EDT
20.51
+0.11 (0.54%)
Pre-market: Jul 31, 2026, 4:30 AM EDT
Scribe Therapeutics Market Cap
Scribe Therapeutics has a market cap or net worth of $384.83 million as of July 31, 2026.
Market Cap
384.83M
Enterprise Value
381.43M
1-Year Change
n/a
Ranking
Category
Stock Price
$20.40
ChartMarket Cap Chart
Since the IPO on July 24, 2026, Scribe Therapeutics's market cap has increased from $242.73M to $384.83M, an increase of 58.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 384.83M | 11.11% |
| Jul 29, 2026 | 346.35M | 1.66% |
| Jul 28, 2026 | 340.69M | -4.80% |
| Jul 27, 2026 | 357.86M | 47.43% |
| Jul 24, 2026 | 242.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Century Therapeutics | 364.32M |
| Enanta Pharmaceuticals | 362.03M |
| Abeona Therapeutics | 355.08M |
| Compass Therapeutics | 349.37M |
| Upstream Bio | 348.83M |
| Rocket Pharmaceuticals | 342.87M |
| DiaMedica Therapeutics | 340.54M |
| Palisade Bio | 340.22M |